Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

OPGN / OpGen, Inc. / Sabby Management, LLC - SABBY 13G OPGN 2.16.18 (Passive Investment)

2018-02-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Opgen, Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 68373L208 (CUSIP Number) February 7, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of this cover p

OPGN / OpGen, Inc. / Sabby Management, LLC - SABBY 13G OPGN 2.16.18 (Passive Investment)

2018-02-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Opgen, Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 68373L208 (CUSIP Number) February 7, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of this cover p

OPGN / OpGen, Inc. / ARMISTICE CAPITAL, LLC - 3G (Passive Investment)

2018-02-12 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No.)*     OpGen, Inc. (Name of Issuer)     Common Stock, par value $0.01 per share (Title of Class of Securities)     68373L208 (CUSIP Number)     February 1, 2018 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b)   [X] Rule 13d-1(c)   [_] Ru

OPGN / OpGen, Inc. / ARMISTICE CAPITAL, LLC - 3G (Passive Investment)

2018-02-12 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No.)*     OpGen, Inc. (Name of Issuer)     Common Stock, par value $0.01 per share (Title of Class of Securities)     68373L208 (CUSIP Number)     February 1, 2018 (Date of Event Which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b)   [X] Rule 13d-1(c)   [_] Ru

OPGN / OpGen, Inc. / INTRACOASTAL CAPITAL, LLC - SCHEDULE 13G (Passive Investment)

2018-02-12 sec.gov
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934   (Amendment No. )*   OpGen, Inc.   (Name of Issuer)   Common Stock, $0.01 par value per share   (Title of Class of Securities)   68373L208 (CUSIP Number)   February 1, 2018   (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   a.

OPGN / OpGen, Inc. / INTRACOASTAL CAPITAL, LLC - SCHEDULE 13G (Passive Investment)

2018-02-12 sec.gov
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934   (Amendment No. )*   OpGen, Inc.   (Name of Issuer)   Common Stock, $0.01 par value per share   (Title of Class of Securities)   68373L208 (CUSIP Number)   February 1, 2018   (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   a.

OPGN / OpGen, Inc. / Merck Global Health Innovation Fund, LLC - SC 13D/A (Activist Investment)

2018-02-08 sec.gov
SC 13D/A     SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549     SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)     OPGEN, INC. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 68373L208 (CUSIP Number) William Taranto, President Merck Global Health Innovation Fund, LLC One Merck Drive Whitehouse Station, NJ 08889 908-423-6551 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) July 18, 2017

OPGN / OpGen, Inc. / Merck Global Health Innovation Fund, LLC - SC 13D/A (Activist Investment)

2018-02-08 sec.gov
SC 13D/A     SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549     SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)     OPGEN, INC. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 68373L208 (CUSIP Number) William Taranto, President Merck Global Health Innovation Fund, LLC One Merck Drive Whitehouse Station, NJ 08889 908-423-6551 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) July 18, 2017

OPGN / OpGen, Inc. / Empery Asset Management, LP - OPGEN, INC. (Passive Investment)

2018-02-08 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G     Under the Securities Exchange Act of 1934   (Amendment No.   )*   OpGen, Inc. (Name of Issuer)   Common Stock, $0.01 par value (Title of Class of Securities)   68373L109 (CUSIP Number)   February 1, 2018 (Date of event which requires filing of this statement)     Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:   ¨ Rule 13d-1(b) x Rule 13d-1(c) ¨ Rule 13d-1(d)   (Page 1 of

OPGN / OpGen, Inc. / Empery Asset Management, LP - OPGEN, INC. (Passive Investment)

2018-02-08 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G     Under the Securities Exchange Act of 1934   (Amendment No.   )*   OpGen, Inc. (Name of Issuer)   Common Stock, $0.01 par value (Title of Class of Securities)   68373L109 (CUSIP Number)   February 1, 2018 (Date of event which requires filing of this statement)     Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:   ¨ Rule 13d-1(b) x Rule 13d-1(c) ¨ Rule 13d-1(d)   (Page 1 of

OPGN / OpGen, Inc. PROSPECTUS (Prospectus)

2018-02-05 sec.gov
Prospectus Filed Pursuant to Rule 424(b)(4) Registration Statement File No. 333-222140 and Registration Statement File No. 333-222830            2,841,152 Units (each Unit contains One Share of Common Stock and One Common Warrant to purchase 0.5 of a Share of Common Stock) 851,155 Pre-funded Units (each Pre-funded Unit contains One Pre-funded Warrant to Purchase One Share of Common Stock and 1 Common Warrant to purchase 0.

OPGN / OpGen, Inc. FORM 8-K (Current Report)

2018-02-02 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________ FORM 8-K _________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 1, 2018 Date of Report (date of earliest event reported) _________________ OpGen, Inc. (Exact name of Registrant as specified in its charter) _________________ Delaware (State or other jurisdiction of incorporation or organization)   001-37367 (Commission File Number)   06-1614015 (I.

OPGN / OpGen, Inc. FORM S-1MEF

2018-02-02 sec.gov
As filed with the Securities and Exchange Commission on February 1, 2018 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 ___________________ OPGEN, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 8071 (Primary Standard Industrial Classification Code Number) 06-1614015 (I.

OPGN / OpGen, Inc. FORM S-1/A

2018-01-31 sec.gov
As filed with the Securities and Exchange Commission on January 31, 2018 Registration No. 333-222140 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 ___________________ OPGEN, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 8071 (Primary Standard Industrial Classification Code Number) 06

OPGN / OpGen, Inc. FORM 8-K (Current Report)

2018-01-29 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________ FORM 8-K _________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 29, 2018 Date of Report (date of earliest event reported) _________________ OpGen, Inc. (Exact name of Registrant as specified in its charter) _________________ Delaware (State or other jurisdiction of incorporation or organization)   001-37367 (Commission File Number)   06-1614015 (I.


OPGN : OpGen Stock Analysis and Research Report

OpGen was incorporated in Delaware in 2001. The Company’s headquarters are in Gaithersburg, Maryland, and its principal operations are in Gaithersburg, Maryland and Woburn, Massachusetts. The Company also has operations in Copenhagen, Denmark. The Company operates in one business segment.

OpGen is a precision medicine company using molecular diagnostics and informatics to help combat infectious disease. The Company is developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections.

The Company’s molecular diagnostics and informatics...

Click for full article
CUSIP: 68373L208